SEROEPIDEMIOLOGY OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I/II IN BENIN (WEST AFRICA)

被引:49
作者
DUMAS, M
HOUINATO, D
VERDIER, M
ZOHOUN, T
JOSSE, R
BONIS, J
ZOHOUN, I
MASSOUGBODJI, A
DENIS, F
机构
[1] CHU COTONOU,EPIDEMIOL & SANTE PUBL LAB,COTONOU,BENIN
[2] CHU DUPUYTREN,DEPT BACTERIOL VIROL,F-87042 LIMOGES,FRANCE
[3] CHU COTONOU,CTR TRANSFUS SANGUINE,COTONOU,BENIN
[4] MINIST SANTE BENIN,COTONOU,BENIN
关键词
D O I
10.1089/aid.1991.7.447
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 1988-1989, a national survey was conducted in Benin to determine the distribution of HTLV-I infection in a representative sample of adult individuals. This study comprised 2625 healthy subjects recruited in the six provinces of Benin and 1300 blood donors from Cotonou and from the other five provinces. Sera were screened for HTLV-I antibody by both immunofluorescence (IF) and enzyme immunoassay (EIA). Sera positive or doubtful by at least one technique were further analyzed by Western blot and radioimmunoprecipitation assay (RIPA) when indeterminate. Samples were considered as positive if they reacted with two gene products. No blood donor was positive. Over the 2625 subjects, 39 (1.5%) were positive. We observed a statistical difference between male and female (1%, 2%, p < 0.05). A difference was also observed according to the areas studied: the HTLV-I antibody rate increased from coastal (0.3%) to northern (5.4%) provinces. HTLV-I seroprevalence increased significantly with age. This survey shows that HTLV-I infection exists in Benin but varies according to regions.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 16 条
[1]   REGIONAL VARIATION IN PREVALENCE OF ANTIBODY AGAINST HUMAN LYMPHOTROPIC-T VIRUS TYPE-1 AND TYPE-3 IN KENYA, EAST-AFRICA [J].
BIGGAR, RJ ;
JOHNSON, BK ;
OSTER, C ;
SARIN, PS ;
OCHENG, D ;
TUKEI, P ;
NSANZE, H ;
ALEXANDER, S ;
BODNER, AJ ;
SIONGOK, TA ;
GALLO, RC ;
BLATTNER, WA .
INTERNATIONAL JOURNAL OF CANCER, 1985, 35 (06) :763-767
[2]   TYPE-I HTLV ANTIBODY IN URBAN AND RURAL GHANA, WEST-AFRICA [J].
BIGGAR, RJ ;
SAXINGER, C ;
GARDINER, C ;
COLLINS, WE ;
LEVINE, PH ;
CLARK, JW ;
NKRUMAH, FK ;
BLATTNER, WA .
INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (02) :215-219
[3]   EPIDEMIOLOGY OF HTLV-I IN GABON (WESTERN EQUATORIAL AFRICA) [J].
DELAPORTE, E ;
DUPONT, A ;
PEETERS, M ;
JOSSE, R ;
MERLIN, M ;
SCHRIJVERS, D ;
HAMONO, B ;
BEDJABAGA, L ;
CHERINGOU, H ;
BOYER, F ;
BRUNVEZINET, F ;
LAROUZE, B .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (05) :687-689
[4]  
DELAPORTE E, 1989, J ACQ IMMUN DEF SYND, V2, P410
[5]  
DETHE G, 1985, CANCER RES, V45, P4633
[6]   SPORADIC CARRIERS OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN NORTHERN EGYPT [J].
ELFARRASH, MA ;
BADR, MF ;
HAWAS, SA ;
ELNASHAR, NM ;
IMAI, J ;
KOMODA, H ;
HINUMA, Y .
MICROBIOLOGY AND IMMUNOLOGY, 1988, 32 (09) :981-984
[7]  
GESSAIN A, 1985, LANCET, V2, P407
[8]   ANTIBODIES TO ADULT T-CELL LEUKEMIA-VIRUS-ASSOCIATED ANTIGEN (ATLA) IN SERA FROM PATIENTS WITH ATL AND CONTROLS IN JAPAN - A NATION-WIDE SERO-EPIDEMIOLOGIC STUDY [J].
HINUMA, Y ;
KOMODA, H ;
CHOSA, T ;
KONDO, T ;
KOHAKURA, M ;
TAKENAKA, T ;
KIKUCHI, M ;
ICHIMARU, M ;
YUNOKI, K ;
SATO, I ;
MATSUO, R ;
TAKIUCHI, Y ;
UCHINO, H ;
HANAOKA, M .
INTERNATIONAL JOURNAL OF CANCER, 1982, 29 (06) :631-635
[9]   ANTIBODIES TO ATLV/HTLV-1 IN AFRICA [J].
HUNSMANN, G ;
BAYER, H ;
SCHNEIDER, J ;
SCHMITZ, H ;
KERN, P ;
DIETRICH, M ;
BUTTNER, DW ;
GOUDEAU, AM ;
KULKARNI, G ;
FLEMING, AF .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1984, 173 (03) :167-170
[10]  
LAROUZE B, 1985, CANCER RES, V45, P4630